Irish-founded Woebot secures $9.5m from pharma giant Bayer
San Francisco-headquartered company has secured over $123.5m in funding to date
Stay updated with breaking news from Jurgen Eckhardt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
San Francisco-headquartered company has secured over $123.5m in funding to date
Published: Jun 09, 2021 By Mark Terry Kojin Therapeutics launched with a $60 million Series A to initially focus on oncology and cell state biology. The round was led by Polaris Partners, Newpath Partners, and Cathay Health, affiliated to Cathay Capital. Participants included Leaps by Bayer, AbbVie, Eventide Asset Management, Alexandria, the Dana-Farber Cancer Institute’s Binney Street Capital, and several family offices. The approach came out of the laboratoryof Stuart Schreiber, Harvard University professor and co-founder of the Broad Institute. Co-founders of Kojin include Benj...